BioLife Solutions Inc (BLFS)
- Exchange
- NASDAQ
- Symbol
- BLFS
- Sector
- Life Sciences
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open26.89
-
High27.36
-
Low26.04
-
Close26.60
-
Volume383,998
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
2.46
Receivables turnover
7.65
Payables turnover
15.38
Working capital turnover
1.82
Days of inventory on hand (DOH)
148.62
Days of sales outstanding (DSO)
47.69
Number of days of payables
23.74
Fixed asset turnover
6.77
Total asset turnover
0.35
Current ratio
2.86
Quick ratio
1.67
Cash ratio
1.23
Cash conversion cycle
172.58
Debt-to-assets ratio
0.04
Debt-to-capital ratio
0.05
Debt-to-equity ratio
0.05
Financial leverage ratio
1.22
Interest coverage
-5,447.92
Gross profit margin
25.26%
Operating profit margin
-49.60%
Pretax margin
-46.40%
Net profit margin
-46.52%
Operating return on assets (Operating ROA)
-17.16%
Return on assets (ROA)
-16.10%
Return on total capital
-19.90%
Return on equity (ROE)
-19.67%